Document Detail


Revolution in mitochondrial medicine.
MedLine Citation:
PMID:  10437772     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A revolution in chemical pathology occurred about 40 years ago with the discovery of a patient with mitochondrial dysfunction. The field of mitochondrial medicine has experienced explosive growth during the last decade. More than 50 mtDNA mutations and several nuclear gene mutations have been identified in affected patients. The recent development of animal models will continue the revolution in mitochondrial medicine by facilitating in depth studies of the molecular pathogenesis and development of novel drug and gene therapy strategies for mitochondrial dysfunction. As we enter the next millennium, we can expect mitochondrial medicine to remain a dynamic and rapidly developing field.
Authors:
N G Larsson; R Luft
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  FEBS letters     Volume:  455     ISSN:  0014-5793     ISO Abbreviation:  FEBS Lett.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-08-16     Completed Date:  1999-08-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0155157     Medline TA:  FEBS Lett     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  199-202     Citation Subset:  IM    
Affiliation:
Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. nils-goran.larsson@cmm.ki.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aging / genetics,  metabolism
Animals
DNA, Mitochondrial / genetics*
Disease Models, Animal
Humans
Mitochondria / metabolism
Mitochondrial Myopathies / genetics*,  metabolism,  therapy
Mutation
Chemical
Reg. No./Substance:
0/DNA, Mitochondrial

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes in clinic vaccination coverage after institution of measurement and feedback in 4 states and...
Next Document:  Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: implica...